FOR SUPPORT, CALL 1-866-APF-3635 (273-3635)
(NORD) broke previous records with its 2019 Rare Diseases & Orphan Products Breakthrough Summit
Thanks to our supporters the APF has recently earned over $800 from amazonsmile!
Scenesse was approved by the FDA on October 8 as a treatment to increase pain-free time in the light for patients with EPP.
The FDA has granted APPROVAL for Afamelanotide (Scenesse) for the treatment of Erythropoietic Protoporphyria!
